KBC Group NV Increases Stock Holdings in The Cigna Group (NYSE:CI)

KBC Group NV grew its holdings in shares of The Cigna Group (NYSE:CI) by 1.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 550,638 shares of the health services provider’s stock after purchasing an additional 8,077 shares during the period. KBC Group NV owned about 0.20% of The Cigna Group worth $152,053,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in CI. ORG Wealth Partners LLC acquired a new position in The Cigna Group during the 4th quarter worth $34,000. Ulland Investment Advisors LLC lifted its stake in The Cigna Group by 2,500.0% in the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after acquiring an additional 100 shares during the last quarter. Prospera Private Wealth LLC purchased a new stake in shares of The Cigna Group during the 3rd quarter worth $37,000. Harbor Capital Advisors Inc. purchased a new stake in The Cigna Group during the 3rd quarter worth about $45,000. Finally, Intact Investment Management Inc. acquired a new position in The Cigna Group in the third quarter valued at approximately $69,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Price Performance

Shares of NYSE:CI opened at $294.18 on Monday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.72 and a current ratio of 0.72. The business’s fifty day moving average price is $297.18 and its two-hundred day moving average price is $325.59. The stock has a market cap of $81.82 billion, a PE ratio of 27.75, a price-to-earnings-growth ratio of 0.78 and a beta of 0.54. The Cigna Group has a one year low of $262.03 and a one year high of $370.83.

The Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.22 by $0.29. The business had revenue of $63.70 billion for the quarter, compared to the consensus estimate of $59.58 billion. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The company’s quarterly revenue was up 29.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.77 earnings per share. On average, analysts forecast that The Cigna Group will post 28.5 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on CI. Stephens restated an “overweight” rating and issued a $410.00 price objective on shares of The Cigna Group in a research note on Friday, November 1st. Piper Sandler reissued an “overweight” rating and issued a $394.00 price objective (up from $392.00) on shares of The Cigna Group in a research note on Tuesday, November 5th. Barclays increased their target price on The Cigna Group from $405.00 to $420.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a research note on Monday, November 4th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $400.00 target price on shares of The Cigna Group in a research report on Wednesday, October 23rd. One investment analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $395.93.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.